Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
Completed
Conditions studied: Fetal and Neonatal Alloimmune Thrombocytopenia
In brief
A prospective, non-interventional, natural history study to assess the occurrence of higher FNAIT risk across a broad population of different racial and ethnic characteristics and the occurrence of HPA-1a alloimmunization in these women.
Key facts
- Study ID
- NCT05345561
- Run by
- Rallybio
- People needed
- 14390
- Starts
- 2022-03-14
- Expected to finish
- 2025-10-10
- Last updated by the study team
- 2026-03-06
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Pregnant women (≥ 18 years of age) who have provided informed consent for the study.
You may not qualify if…
- Participants with prior history of FNAIT
Where it is running
- New Horizons Clinical Trials, LLC — Chandler, Arizona, United States
- Zillan Clinical Research - Gardena — Gardena, California, United States
- Yale University School of Medicine — New Haven, Connecticut, United States
- University of Miami Miller School of Medicine — Miami, Florida, United States
- Cooper University Hospital — Camden, New Jersey, United States
- Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
- St. Peter's University Hospital — New Brunswick, New Jersey, United States
- Rutgers New Jersey Medical School — Newark, New Jersey, United States
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
- Columbia University Irving Medical Center — New York, New York, United States
- New York-Presbyterian-Queens — New York, New York, United States
- Weill Cornell Medicine-New York Presbyterian Hospital — New York, New York, United States
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
- Ohio State University Wexner Medical Center — Columbus, Ohio, United States
- Wright State Physicians Obstetrics & Gynecology — Dayton, Ohio, United States
- Temple Perinatal Diagnosis Center — Philadelphia, Pennsylvania, United States
- Javara Inc. - Forest — Dallas, Texas, United States
- The University of Texas Health Science Center at Houston — Houston, Texas, United States
- Javara Research Inc. - Dallas - PPDS — Houston, Texas, United States
- Sunnybrook Health Sciences Centre — Toronto, Ontario, Canada
- Klinikum der Friedrich Schiller Universität Jena — Jena, Thuringia, Germany
- Leids Universitair Medisch Centrum — Leiden, South Holland, Netherlands
- Oslo Universitetssykehus HF, Ullevål — Oslo, Oslo, Norway
- Universitetssykehuset Nord Norge — Tromsø, Norway
- Barnmorskestationen Rosengård — Lund, Skåne County, Sweden
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.